Inhibition of allergen-specific IgE reactivity by a human Ig Fcγ-Fcε bifunctional fusion protein

Journal of Allergy and Clinical Immunology

Volumn 114, Issue 2, 2004, Pages 321-327

  Zhang, Ke ^a   Kepley, Christopher L ^c   Terada, Tetsuya ^a   Zhu, Daocheng ^a   Perez, Hector ^c   Saxon, Andrew ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NONE

Author keywords

4 Hydroxy 3 nitrophenylacetyl; Allergen; anaphylaxis; basophils; degranulation; Fc RI; fusion protein; GE2; Human IgG igE Fc fusion protein; IgE; immunotherapy; mast cells; NP; Passive cutaneous anaphylaxis; PCA; PS; transgenic mouse

Indexed keywords

ALLERGEN; HYBRID PROTEIN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN FC FRAGMENT;

ALLERGY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ARTICLE; BASOPHIL; CONTROLLED STUDY; DERMATOPHAGOIDES FARINAE; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ALLERGENS; ANIMALS; BASOPHILS; CELL DEGRANULATION; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN FC FRAGMENTS; MACACA MULATTA; MAST CELLS; MICE; MICE, TRANSGENIC; MITES; RECEPTORS, IGE; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS;

EID: 4344605211     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.03.058     Document Type: Article

References (22)

1. Prescott S.L., Jones C.A. An update of immunotherapy for specific allergies. Curr Drug Targets Inflamm Allergy. 1:2000;65-75
2. Hamelmann E., Rolinck-Werninghaus C., Wahn U. Is there a role for anti-IgE in combination with specific allergen immunotherapy? Curr Opin Allergy Clin Immunol. 3:2003;501-510
3. Barnes P.J. Cytokine-directed therapies for the treatment of chronic airway diseases. Cytokine Growth Factor Rev. 14:2003;511-522
4. Rosenwasser L.J., Busse W.W., Lizambri R.G., Olejnik T.A., Totoritis M.C. Allergic asthma and an anti-CD23 mAb (IDEC-152): results of a phase I, single-dose, dose-escalating clinical trial. J Allergy Clin Immunol. 112:2003;563-570
5. Alexander C., Kay A.B., Larche M. Peptide-based vaccines in the treatment of specific allergy. Curr Drug Targets Inflamm Allergy. 1:2002;353-361
6. Hussain I., Kline J.N. CpG oligodeoxynucleotides: a novel therapeutic approach for atopic disorders. Curr Drug Targets Inflamm Allergy. 2:2003;199-205
7. Zhu D., Kepley C.L., Zhang M., Zhang K., Saxon A. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation. Nat Med. 8:2002;518-521
8. Kepley C.L., Zhang K., Zhu D., Saxon A. FcepsilonRI-FcgammaRII coaggregation inhibits IL-16 production from human Langerhans-like dendritic cells. Clin Immunol. 108:2003;89-94
9. Yamada T., Zhu D., Zhang K., Saxon A. Inhibition of interleukin-4-induced class switch recombination by a human immunoglobulin Fc gamma-Fc epsilon chimeric protein. J Biol Chem. 278:2003;32818-32824
10. Kepley C.L., Cambier J.C., Morel P.A., Lujan D., Ortega E., Wilson B.S., et al. Negative regulation of FcepsilonRI signaling by FcgammaRII costimulation in human blood basophils. J Allergy Clin Immunol. 106:1998;337-348
11. Kambe N., Kambe M., Kochan J.P., Schwartz L.B. Human skin-derived mast cells can proliferate while retaining their characteristic functional and protease phenotypes. Blood. 97:2001;2045-2052
12. Kepley C.L., Craig S.S., Schwartz L.B. Identification and partial characterization of a unique marker for human basophils. J Immunol. 154:1995;6548-6555
13. Dombrowicz D., Brini A.T., Flamand V., Hicks E., Snouwaert J.N., Kinet J.P., et al. Anaphylaxis mediated through a humanized high affinity IgE receptor. J Immunol. 157:1996;1645-1651
14. Dombrowicz D., Lin S., Flamand V., Brini A.T., Koller B.H., Kinet J.P. Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses. Immunity. 8:1998;517-529
15. Schelegle E.S., Gershwin L.J., Miller L.A., Fanucchi M.V., Van Winkle L.S., Gerriets J.P., et al. Allergic asthma induced in rhesus monkeys by house dust mite (Dermatophagoides farinae). Am J Pathol. 158:2001;333-341
16. Benoist C., Mathis D. Mast cells in autoimmune disease. Nature. 420:2002;875-879
17. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 297:2002;1689-1692
18. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J Neurol Sci. 122:1994;210-213
19. Secor V.H., Secor W.E., Gutekunst C.A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med. 191:2000;813-822
20. Steinman L. Multiple sclerosis: a two-stage disease. Nat Immunol. 2:2001;762-764
21. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol. 37:1995;63-66
22. Chen R., Ning G., Zhao M.L., Fleming M.G., Diaz L.A., Werb Z., et al. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 108:2001;1151-1158